Additionally, in a meta-analysis by Olsson et al., p-tau levels were strongly related with mild cognitive impairment due to Alzheimer’s disease, with a diagnostic performance of 1.88 (95% CI: 1.79–1.97, p < 0.0001) [27] (Table 1). This evidence concerns the gene MAPT and Alzheimer disease.